Australia's most trusted
source of pharma news
Tuesday, 28 July 2026
A drug that's taking off globally with 71 per cent sales growth is embarrassingly behind in Australia where it's experiencing a gruelling wait for a PBS listing for an indication that 29 other countries have reimbursed.